Advancing Clinical Research in Turkey, Middle East & North Africa
Industry sponsored clinical trials are increasingly conducted in emerging regions, due to escalating competition
and high costs in the more established territories of North America and Western Europe. As companies search for advantages and new opportunities, factors such as large and eager patient populations, competitive trial budgets, and faster recruitment rates at fewer sites are prompting a fundamental geographic shift in the location of studies.
While the development of Turkey, the Middle East and North African region has been limited so far, currently there is a renewed and growing interest as governments are beginning to take measures to improve regulatory requirements and harmonise clinical trial laws in order to become more involved in clinical research activities.
With it's close proximity to Europe, a large treatment naive patient population who otherwise lack access to advanced therapies, and highly motivated, Western trained capable investigative teams the Middle East and North Africa represent the last relatively untapped markets. Local knowledge and early involvement will be essential factors in generating success.
NextLevel Pharma's "Advancing clinical research in Turkey, the Middle East and North Africa" will bring together the local regulators and ethics committees, alongside experienced investigators with clinical trial experts from pharma and CROs. It will examine in detail, the key regulatory, clinical, outsourcing and environmental factors which impact clinical trials. Particular and specific attention will be given to Turkey, Egypt, Saudi Arabia, the Gulf States, Jordan & Lebanon via separate, focused conference sessions.
NextLevel Pharma's inaugural meeting on the region will provide dedicated, 1 on 1 partnering sessions enabling trial sponsor companies to meet with leading clinical solution providers in the region to discuss potential partnerships
and drive forward clinical programmes in an exciting and dynamic region.
Why Attend?
- Gain vital local knowledge by hearing updates on the varied and changing clinical regulations.
- Adapt your tactics to train, motivate and retain the clinical teams and patients in these specific regions.
- Discover what is the most efficient operating model for the region to maximise the performance of your study.
- Case study presentations from experts active in Turkey, the Middle East and the North Africa region
- Partner with the leading clinical solution providers from Turkey and MENA in our exclusive 1-on-1 partnering sessions.
- Network and build the contacts & relationships you need at NextLevel Pharma's very popular & entertaining networking dinner.
Who will benefit:
Pharmaceutical & Biotechnology Organisations:
Global / European / Regional / Country Heads of Clinical Operations,Clinical Development, Outsourcing, Contract Management,Risk Management, R&D Sourcing, Business Development, Project & Study Managers.
CROs & Clinical Solution Providers:
CEOs, Business Development Directors, Product Managers, Marketing Managers and Country Managers from the region.
Your prestigious speaker panel
|
Industry
Pharma Development Organisation Deputy Regional Head New Territories, Roche, Turkey
Medical Investigation Manager, Nobel, Turkey
MEA Global Clinical Trials Organisation Lead, MSD, Turkey
Clinical Research Manager / Country Clinical Operations Sourcing Lead (Middle East) Pfizer United Arab Emirates (TBC)
Clinical Research Manager Genethon, France
Clinical Research Unit Head Sanofi-Aventis, Turkey
CROs & Expert Solution Providers
Business Development Director MEK Consulting, Lebanon
International Clinical Business Development Manager, ZEINCRO, Turkey
Senior Regional Director Middle East, Clinical Development Services, Quintiles, Austria
Director of Research and Publication, Saudi Food and Drug Authority, Kingdom of Saudi Arabia
|
Head of Clinical Trial Unit, Jordanian FDA, Jordan
Advisor & Coordinator Health Systems Research, Health Information Systems & Medical Education, Ministry of Health, United Arab Emirates
Investigators and Academia
Research Scientist, Vice Chair Research Ethics Committee U.S. Naval Medical Research Unit#3 (NAMRU-3), Egypt
Associate Professor of Public Health Vice Chair of FMBSU REC Director of FMBSU Medical Education Center, Certified Trainer for Human Research Protection, Faculty of Medicine - BSU, Egypt
Assistant prof.of Physiology, Executive administrative Director of Alexandria Clinical Research Center, Faculty of Medicine, Alexandria University and Certified Trainer for Clinical Research, Egypt
Department of Hematology, Ankara University Medical School, Turkey
Director, Office of Clinical Research and Cancer Registry, King Hussein Cancer center, Jordan
Professor of Medicine & Program Director, Middle East Research Ethics Training Initiative University of Maryland School of Medicine, USA
|
Group Leader PDOA, Roche, Turkey
MEA Global Clinical Trials Organisation Lead, MSD, Turkey
Head of Clinical Trials Unit, Turkish Ministry of Health, Turkey
Research Scientist Vice Chair Research Ethics Committee, NAMRU-3 Navy Medical Research Unit – 3 (NAMRU-3), Egypt
Director of Research and Publication, Saudi Food and Drug Authority, Kingdom
of Saudi Arabia
Head of Clinical Trial Unit, Jordanian FDA, Jordan
Associate Professor of Public Health, Vice Chair of FMBSU REC, Director of FMBSU Medical Education Center, Certified Trainer for Human Research Protection
Faculty of Medicine - BSU, Egypt
To be confirmed
Head Clinical Unit , Egyptian Ministry of Health
MSD Turkey Head of Clinical Trials
Sanofi Aventis Medical Director
Pfizer Clinical Research Manager Gulf States &
Country Clinical Operations Sourcing Lead
(Africa & Middle East)